Hemostasis Today

November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Dimitrios Hatzichristou: Advancing Standardization and Quality Control in Platelet-Rich Plasma Therapy
Nov 21, 2026, 03:43

Dimitrios Hatzichristou: Advancing Standardization and Quality Control in Platelet-Rich Plasma Therapy

Dimitrios Hatzichristou, Founder and President at Institute for the Study of Urologic Diseases, shared a post on LinkedIn:

“What PRP do we prepare, and how do we know?

Today, at the 6th Global Regenerative Congress in Paphos, Cyprus, a multidisciplinary consensus initiative begins to develop shared principles for the preparation, quality control, and clinical application of platelet-rich plasma (PRP).

The congress brings together researchers and clinicians from basic research, molecular genetics, bioengineering, pathology, hematology and transfusion medicine, orthopedics, sports medicine, rehabilitation, pain medicine, urology, gynecology, endocrinology, gastroenterology, neurology, plastic surgery, maxillofacial surgery, and dermatology.

Each discipline sees a different part of the process.

Together, we can agree on what to measure and document across the chain of responsibility, from system design and validation to preparation, administration, and patient follow-up.

This effort is critical. A recurring weakness in the published literature is that studies report outcomes after PRP treatment without enough detail about how the preparation was made, what it contained, or how many platelets were administered.

In my view, differences in preparation and dose are likely to explain most of the wide variation in published outcomes.

That makes impossible to evaluate comparable interventions or to determine what accounts for differences in their results.

Two questions frame the discussion for me:

  • What type of PRP has the system been shown to produce consistently?
  • What did we prepare from this patient’s blood, and what did we actually administer?

Thank you Michalis Chrysostomou , Dzihan Abazovic, Global Regenerative Academy Inc., for bringing so many experts and disciplines together to work toward shared standards for PRP.”

Dimitrios Hatzichristou: Advancing Standardization and Quality Control in Platelet-Rich Plasma Therapy

Stay updated with Hemostasis Today.